27
MAR
2014
Northwest Biotherapeutics to Present at the 4th Annual “Cancer Immunotherapy: A Long-Awaited Reality” Conference
Comments : Off
BETHESDA, MD, March 27, 2014 – Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) (“NW Bio”), a biotechnology company developing non-toxic DCVax® personalized immune therapies for cancer, announced today that Linda Powers, CEO, will present at the 4th Annual “Cancer Immunotherapy: A Long-Awaited Reality” conference being held at the New York Academy of Medicine in New York City on Thursday, March 27 at 2:45 pm ET. During her presentation,... Read More